<VariationArchive VariationID="626790" VariationName="NM_000432.4(MYL2):c.431_432del (p.Pro144fs)" VariationType="Deletion" Accession="VCV000626790" Version="16" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="7" DateLastUpdated="2024-05-08" DateCreated="2019-05-06" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="615035" VariationID="626790">
      <GeneList>
        <Gene Symbol="MYL2" FullName="myosin light chain 2" GeneID="4633" HGNC_ID="HGNC:7583" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q24.11</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="110910845" stop="110921449" display_start="110910845" display_stop="110921449" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="111348622" stop="111358403" display_start="111348622" display_stop="111358403" Strand="-" />
          </Location>
          <OMIM>160781</OMIM>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000432.4(MYL2):c.431_432del (p.Pro144fs)</Name>
      <CanonicalSPDI>NC_000012.12:110911145:AG:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>12q24.11</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="110911146" stop="110911147" display_start="110911146" display_stop="110911147" variantLength="2" positionVCF="110911145" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="111348950" stop="111348951" display_start="111348950" display_stop="111348951" variantLength="2" positionVCF="111348949" referenceAlleleVCF="CAG" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>P144fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.111348950_111348951del" Assembly="GRCh37">
            <Expression>NC_000012.11:g.111348950_111348951del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.110911146_110911147del" Assembly="GRCh38">
            <Expression>NC_000012.12:g.110911146_110911147del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007554.1" sequenceAccession="NG_007554" sequenceVersion="1" change="g.14431_14432del">
            <Expression>NG_007554.1:g.14431_14432del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000432.4" sequenceAccession="NM_000432" sequenceVersion="4" change="c.431_432del" MANESelect="true">
            <Expression>NM_000432.4:c.431_432del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000423.2" sequenceAccession="NP_000423" sequenceVersion="2" change="p.Pro144fs">
            <Expression>NP_000423.2:p.Pro144fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_393" sequenceAccession="LRG_393">
            <Expression>LRG_393:g.14431_14432del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_393t1" sequenceAccession="LRG_393t1">
            <Expression>LRG_393t1:c.431_432del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_393p1" sequenceAccession="LRG_393p1" change="p.Pro144fs">
            <Expression>LRG_393p1:p.Pro144fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000432.3" sequenceAccession="NM_000432" sequenceVersion="3" change="c.431_432delCT">
            <Expression>NM_000432.3:c.431_432delCT</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="160781.0009" DB="OMIM" />
        <XRef Type="rs" ID="1566147422" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="loss_of_function_variant">
        <XRef ID="SO:0002054" DB="Sequence Ontology" />
      </FunctionalConsequence>
      <FunctionalConsequence Value="decreased_translational_product_level">
        <XRef ID="SO:0001555" DB="Sequence Ontology" />
      </FunctionalConsequence>
      <FunctionalConsequence Value="effect on protein degradation">
        <XRef ID="0051" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000432.4(MYL2):c.431_432del (p.Pro144fs) AND Cardiomyopathy" Accession="RCV000770390" Version="10">
        <ClassifiedConditionList TraitSetID="8589">
          <ClassifiedCondition DB="MedGen" ID="C0878544">Cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
            <Description DateLastEvaluated="2023-04-27" SubmissionCount="2">Conflicting interpretations of pathogenicity</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431_432del (p.Pro144fs) AND Hypertrophic cardiomyopathy 10" Accession="RCV001089865" Version="1">
        <ClassifiedConditionList TraitSetID="3886">
          <ClassifiedCondition DB="MedGen" ID="C1834460">Hypertrophic cardiomyopathy 10</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-03-17" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431_432del (p.Pro144fs) AND Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy" Accession="RCV001553794" Version="2">
        <ClassifiedConditionList TraitSetID="69132">
          <ClassifiedCondition DB="MedGen" ID="C5561937">Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2021-08-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431_432del (p.Pro144fs) AND Congenital myopathy with fiber type disproportion" Accession="RCV001507317" Version="1">
        <ClassifiedConditionList TraitSetID="1240">
          <ClassifiedCondition DB="MedGen" ID="C0546264">Congenital myopathy with fiber type disproportion</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-05-27" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431_432del (p.Pro144fs) AND Cardiovascular phenotype" Accession="RCV003166034" Version="2">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-02-03" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000432.4(MYL2):c.431_432del (p.Pro144fs) AND Hypertrophic cardiomyopathy" Accession="RCV003999941" Version="2">
        <ClassifiedConditionList TraitSetID="17368">
          <ClassifiedCondition DB="MedGen" ID="C0007194">Hypertrophic cardiomyopathy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-28" SubmissionCount="1">Uncertain significance</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-28" NumberOfSubmissions="7" NumberOfSubmitters="7" DateCreated="2019-05-06" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, conflicting classifications</ReviewStatus>
        <Description>Conflicting classifications of pathogenicity</Description>
        <Explanation DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(3)</Explanation>
        <Citation Type="general">
          <ID Source="PubMed">28855170</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32453731</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32600061</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33731536</ID>
        </Citation>
        <Comment DataSource="ClinVar" Type="public">Pathogenic(1); Likely pathogenic(1); Uncertain significance(3)</Comment>
        <DescriptionHistory Dated="2020-06-22">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="17368" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="22501" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy</ElementValue>
                <XRef ID="HP:0001639" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0005045" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">HYPERTROPHIC MYOCARDIOPATHY</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20518" />
                <XRef ID="20518" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="217569" DB="Orphanet" />
              <XRef ID="C0007194" DB="MedGen" />
              <XRef ID="D002312" DB="MeSH" />
              <XRef ID="MONDO:0005045" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001639" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3886" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="677" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CARDIOMYOPATHY, HYPERTROPHIC, MID-LEFT VENTRICULAR CHAMBER TYPE, 2</ElementValue>
                <XRef Type="MIM" ID="608758" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Familial hypertrophic cardiomyopathy 10</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MYL2-Related Familial Hypertrophic Cardiomyopathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hypertrophic cardiomyopathy 10</ElementValue>
                <XRef ID="MONDO:0012112" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CMH10</ElementValue>
                <XRef Type="MIM" ID="608758" DB="OMIM" />
              </Symbol>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301725</ID>
                <ID Source="BookShelf">NBK1768</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21267010</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="C1834460" DB="MedGen" />
              <XRef ID="MONDO:0012112" DB="MONDO" />
              <XRef Type="MIM" ID="608758" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="69132" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="57186" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy</ElementValue>
                <XRef ID="MONDO:0859168" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MFM12</ElementValue>
                <XRef Type="MIM" ID="619424" DB="OMIM" />
              </Symbol>
              <XRef ID="C5561937" DB="MedGen" />
              <XRef ID="MONDO:0859168" DB="MONDO" />
              <XRef Type="MIM" ID="619424" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1240" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5593" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital Fiber-Type Disproportion</ElementValue>
                <XRef ID="NBK1259" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Congenital myopathy with fiber type disproportion</ElementValue>
                <XRef ID="Congenital+Fiber+Type+Disproportion/1827" DB="Genetic Alliance" />
                <XRef ID="240084007" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Congenital fiber-type disproportion myopathy</ElementValue>
                <XRef ID="MONDO:0009711" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">CFTDM</ElementValue>
                <XRef Type="MIM" ID="255310" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="keyword">TPM3-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">all</Attribute>
                <XRef ID="GTR000276064" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SELENON-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6161" />
                <XRef ID="6161" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">ACTA1-Related Congenital Fiber-Type Disproportion</Attribute>
              </AttributeSet>
              <XRef ID="2020" DB="Orphanet" />
              <XRef ID="C0546264" DB="MedGen" />
              <XRef ID="MONDO:0009711" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8589" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="16502" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cardiomyopathy</ElementValue>
                <XRef ID="Cardiomyopathy/1090" DB="Genetic Alliance" />
                <XRef ID="HP:0001638" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0004994" DB="MONDO" />
                <XRef ID="85898001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cardiomyopathies</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CMYO</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="20096" />
                <XRef ID="20096" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="11958" />
                <XRef ID="11958" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="mode of inheritance">Various modes of inheritance</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="AHRQ, 2013">
                <ID Source="BookShelf">NBK248310</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <XRef ID="167848" DB="Orphanet" />
              <XRef ID="C0878544" DB="MedGen" />
              <XRef ID="MONDO:0004994" DB="MONDO" />
              <XRef Type="primary" ID="HP:0001638" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2466042" SubmissionDate="2020-04-20" DateLastUpdated="2020-05-04" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="MYL2:p.Pro144Argfs*57|OMIM:608758" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001245294" DateUpdated="2020-05-04" DateCreated="2020-05-04" Type="SCV" Version="1" SubmitterName="Garg Lab, Nationwide Children's Hospital" OrgID="500097" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-03-17">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The variant is observed to be pathogenic only if homozygous, at least for the infantile presentation, and not pathogenic (or weakly expressed with no obvious disease) if heterozygous</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <GeographicOrigin>Tunisia</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <GeographicOrigin>Tunisia</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">30</Age>
              <Age Type="maximum" age_unit="years">39</Age>
              <AffectedStatus>no</AffectedStatus>
              <Gender>male</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <GeographicOrigin>Tunisia</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>no</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="VariantChromosomes" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <FunctionalConsequence Value="loss_of_function_variant">
            <XRef DB="Sequence Ontology" ID="SO:0002054" URL="http://www.sequenceontology.org/browser/current_svn/term/SO:0002054" />
          </FunctionalConsequence>
          <FunctionalConsequence Value="decreased_translational_product_level">
            <XRef DB="Sequence Ontology" ID="SO:0001555" URL="http://www.sequenceontology.org/browser/current_svn/term/SO:0001555" />
          </FunctionalConsequence>
          <FunctionalConsequence Value="effect on protein degradation">
            <XRef DB="Variation Ontology" ID="0051" URL="http://www.variationontology.org/cgi-bin/amivario/term-details.cgi?term=VariO:0051" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000432.3:c.431_432delCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="608758" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7304149</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3372698" SubmissionDate="2021-06-07" DateLastUpdated="2021-06-15" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="2017-C39-1" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001712278" DateUpdated="2021-06-15" DateCreated="2021-06-15" Type="SCV" Version="1" SubmitterName="Department of Pediatrics, The University of Tokyo" OrgID="508131" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>inherited</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
              <FamilyData SegregationObserved="yes">
                <FamilyHistory>yes</FamilyHistory>
              </FamilyData>
              <Proband>yes</Proband>
            </Sample>
            <Method>
              <TypePlatform>next-gen sequencing</TypePlatform>
              <Purpose>discovery</Purpose>
              <Citation>
                <ID Source="PubMed">33731536</ID>
              </Citation>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="NumberMosaic" integerValue="0" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="1" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SecondaryFinding">no</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="SampleLocalID">2017-C39</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000432.3:c.431_432del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA2020" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9811893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3488861" SubmissionDate="2021-08-06" DateLastUpdated="2021-08-13" DateCreated="2021-08-13">
        <ClinVarSubmissionID localKey="160781.0009_MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY" title="MYL2, 2-BP DEL, 431CT_MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY" />
        <ClinVarAccession Accession="SCV001774791" DateUpdated="2021-08-13" DateCreated="2021-08-13" Type="SCV" Version="1" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-06">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a male infant, born of consanguineous parents, with infantile-onset myofibrillar myopathy-12 with cardiomyopathy (MFM12; 619424), Manivannan et al. (2020) identified a homozygous 2-bp deletion (c.431_432delCT, NM_000432.3) in exon 6 of the MYL2 gene, predicted to result in a frameshift and termination (Pro144ArgfsTer57) with extension of the reading frame into the 3-prime UTR, leading to the addition of 36 amino acids to the C terminus. The mutation was predicted to disrupt the EF-hand domains in the C terminus. The mutation, which was found by exome sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family and was not present in the gnomAD database. The carrier parents were clinically unaffected. Cardiac muscle tissue from the proband showed decreased protein levels of MYL2 compared to controls, although mRNA levels were similar. In vitro cellular studies showed that the mutant MYL2 variant was degraded by the proteasomal machinery, suggesting instability of the mutant protein. Expression of the mutation failed to rescue developmental lethality and cardiac muscle defects in Myl2-null Drosophila, consistent with a loss-of-function effect. Family history revealed 3 additional sibs of the proband with a similar disorder resulting in death in infancy due to cardiac failure.</Attribute>
              <Citation>
                <ID Source="PubMed">32453731</ID>
              </Citation>
              <XRef DB="OMIM" ID="619424" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <Name>MYL2, 2-BP DEL, 431CT</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">2-BP DEL, 431CT</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="160781.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1766491" SubmissionDate="2021-12-23" DateLastUpdated="2021-12-29" DateCreated="2019-05-06">
        <ClinVarSubmissionID localKey="302748|MedGen:C0878544" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000901831" DateUpdated="2021-12-29" DateCreated="2019-05-06" Type="SCV" Version="3" SubmitterName="CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario" OrgID="1050" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000432.3:c.431_432del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0878544" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10844479</SubmissionName>
          <SubmissionName>SUB7083812</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2666646" SubmissionDate="2024-01-25" DateLastUpdated="2024-02-14" DateCreated="2020-06-22">
        <ClinVarSubmissionID localKey="Db4KrQBSZeoE7-orUyypkW2MKcIDjRvWQ8hgvybgMFA|MedGen:C0878544" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001358331" DateUpdated="2024-02-14" DateCreated="2020-06-22" Type="SCV" Version="3" SubmitterName="Color Diagnostics, LLC DBA Color Health" OrgID="505849" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28855170</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32453731</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33731536</ID>
          </Citation>
          <Comment>This variant deletes 2 nucleotides in exon 7 of the MYL2 gene, creating a frameshift and premature translation stop signal in the last coding exon. This mutant transcript is predicted to escape nonsense-mediated decay and be expressed as a truncated protein. A functional study using patient-derived mRNA showed a slight reduction in active mRNA compared to wild-type controls (PMID: 32453731). This variant has been reported in homozygous state in an individual affected with infantile-onset hypertrophic cardiomyopathy; both heterozygous parents were clinically unaffected (PMID: 32453731). It has also been reported in an individual affected with non-compaction cardiomyopathy (PMID: 33731536) and in an individual affected with left ventricular non-compaction (PMID: 28855170). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Clinical relevance of loss-of-function MYL2 truncation variants in autosomal dominant cardiovascular disorders is not clearly established. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>NGS</TypePlatform>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000432.4:c.431_432del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0878544" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>Color Genomics - ClinVar Submission - May2020 - SUB747</SubmissionName>
          <SubmissionName>SUB10927044</SubmissionName>
          <SubmissionName>SUB14171678</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9030685" SubmissionDate="2024-04-16" DateLastUpdated="2024-04-20" DateCreated="2024-04-20">
        <ClinVarSubmissionID localKey="837449|MONDO:0005045" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004845819" DateUpdated="2024-04-20" DateCreated="2024-04-20" Type="SCV" Version="1" SubmitterName="All of Us Research Program, National Institutes of Health" OrgID="509529" OrganizationCategory="consortium" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain Significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28855170</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32453731</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33731536</ID>
          </Citation>
          <Comment>This variant deletes 2 nucleotides in exon 7 of the MYL2 gene, creating a frameshift and premature translation stop signal in the last coding exon. This mutant transcript is predicted to escape nonsense-mediated decay and be expressed as a truncated protein. A functional study using patient-derived mRNA showed a slight reduction in active mRNA compared to wild-type controls (PMID: 32453731). This variant has been reported in homozygous state in an individual affected with infantile-onset hypertrophic cardiomyopathy; both heterozygous parents were clinically unaffected (PMID: 32453731). It has also been reported in an individual affected with non-compaction cardiomyopathy (PMID: 33731536) and in an individual affected with left ventricular non-compaction (PMID: 28855170). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). Clinical relevance of loss-of-function MYL2 truncation variants in autosomal dominant cardiovascular disorders is not clearly established. The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <NumberTested>108544</NumberTested>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.11:g.111348950_111348951del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0005045" />
          </Trait>
        </TraitSet>
        <Comment>This study involves interpretation of variants in research participants for the purpose of population health screening. Participant phenotype was not available at the time of variant classification. Additional details can be found in publication PMID: 35346344, PMCID: PMC8962531</Comment>
        <SubmissionNameList>
          <SubmissionName>SUB14382316</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7209490" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2023-04-15">
        <ClinVarSubmissionID localKey="a8814989|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003864501" DateUpdated="2024-05-01" DateCreated="2023-04-15" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-02-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Uncertain significance</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28855170</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32453731</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32600061</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33731536</ID>
          </Citation>
          <Comment>The c.431_432delCT variant, located in coding exon 7 of the MYL2 gene, results from a deletion of two nucleotides at nucleotide positions 431 to 432, causing a translational frameshift with a predicted alternate stop codon (p.P144Rfs*57). This alteration occurs at the 3' terminus of theMYL2 gene, is not expected to trigger nonsense-mediated mRNA decay, and impacts the last 13% of the protein. However, premature stop codons are typically deleterious in nature and a significant portion of the protein is affected (Ambry internal data). This alteration has been reported as homozygous in a case report with ventricular hypertrophy and hypotonia, passing away from refractory cardiogenic shock (Manivannan SN et al. PLoS Genet, 2020 May;16:e1008639). Additionally, this alteration was found in trans with an additional alteration in MYL2 in two siblings with muscle weakness and dilated cardiomyopathy (Tamamitsu AM et al. Int Heart J, 2021 Mar;62:445-447). Lastly, this alteration was detected in a left ventricular non-compaction (LVNC) cohort; however, clinical details were limited (Wang C et al. J Am Heart Assoc, 2017 Aug;6:[ePub ahead of print]; Hirono K et al. Circ Genom Precis Med, 2020 Aug;13:e002940). Although biallelic loss of function alterations in MYL2 have been associated with autosomal recessive MYL2-related myofibrillar myopathy with cardiomyopathy, haploinsufficiency for MYL2 has not been clearly established as a mechanism of disease for autosomal dominant MYL2-related cardiomyopathy. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MYL2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000432.3:c.431_432delCT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>FinalAVA3AVA4ClinvarDepositThrough031523</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2666646" TraitType="Disease" MappingType="XRef" MappingValue="C0878544" MappingRef="MedGen">
        <MedGen CUI="C0878544" Name="Cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1766491" TraitType="Disease" MappingType="XRef" MappingValue="C0878544" MappingRef="MedGen">
        <MedGen CUI="C0878544" Name="Cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3488861" TraitType="Disease" MappingType="Name" MappingValue="MYOPATHY, MYOFIBRILLAR, 12, INFANTILE-ONSET, WITH CARDIOMYOPATHY" MappingRef="Preferred">
        <MedGen CUI="C5561937" Name="Myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7209490" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3372698" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA2020" MappingRef="Orphanet">
        <MedGen CUI="C0546264" Name="Congenital myopathy with fiber type disproportion" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9030685" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0005045" MappingRef="MONDO">
        <MedGen CUI="C0007194" Name="Hypertrophic cardiomyopathy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2466042" TraitType="Disease" MappingType="XRef" MappingValue="608758" MappingRef="OMIM">
        <MedGen CUI="C1834460" Name="Hypertrophic cardiomyopathy 10" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

